In addition to the physical execution of early phase studies, whether in Phase I Unit or in Clinical Setting, we offer a broad range of supporting, complementary solutions, like expert advice in assay selection and validations (irrespective of whether analytical or antigenicity assessments), optimization of study design, use of pharmacological provocation tests, deep analysis and interpretation of PK/PD relationships, PK/PD modeling and simulations, in vitro in vivo correlations, early population PK modeling approaches, special medical monitoring, safety signal detection, always ensuring maximal scientific and regulatory compliance.
While planning, conducting, and analyzing your early-phase clinical studies, our primary goal is always to maximize the value of your early-phase clinical program through focused efforts in ensuring quality, scientific integrity, regulatory compliance, innovation, and program acceleration.
Accelerated Delivery is Accelsiors’ experience-driven dynamic planning and operational model – the harmonization of our scientific expertise, wide reaching services, quality insights, advanced clinical research technology, proactivity and tailored collaboration approach.
Explore our powerful suite of solutions built to accelerate delivery of quality results in clinical drug development!
We offer a complete set of Early Phase Clinical Development Services to properly handle constantly moving elements of your first-in-humans and proof-of-concept studies: